EP4547676A1 — Cyclic boronic esters and their uses
Assigned to Principia Biopharma Inc · Expires 2025-05-07 · 1y expired
What this patent protects
The present disclosure relates to cyclic boronic esters and salts thereof for use as immunoproteasome inhibitors. The disclosure further relates to pharmaceutical compositions, methods of preparing, crystal and polymorph forms, and methods of treatment relating to the same.
USPTO Abstract
The present disclosure relates to cyclic boronic esters and salts thereof for use as immunoproteasome inhibitors. The disclosure further relates to pharmaceutical compositions, methods of preparing, crystal and polymorph forms, and methods of treatment relating to the same.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.